The market's willingness to pay 2.24x book while the tabulated ROE sits at 3.8% for 2026Q3 suggests investors are underwriting a return path materially above the current reported run rate, so the multiple appears to embed ROTCE expansion that the ten-quarter record has not yet demonstrated. Tangible book per share has compounded from $18.35 to $27.16, roughly 48% over the period, which means the price has risen faster than book — the 58.70 price against $27.16 TBV is a valuation premium rather than a book-driven artifact, and it warrants scrutiny against the declining fee contribution.

In DuPont terms, the entire ROE trajectory is explained by the denominator: ROA has been remarkably stable within a 20bp band, so the 40% increase in the equity/assets ratio has mechanically reduced the leverage multiplier from roughly 10x to about 7x. This implies the profitability problem is one of capital deployment rather than pricing or cost control, though the fall in fee income share from 14.8% to 4.6% is now beginning to pressure the ROA leg as well, which would make the dilution harder to reverse through retained earnings alone.

NIM compression of 20bp alongside an efficiency ratio worsening of 4.2 points suggests the issue is not purely funding cost — it appears to be revenue contracting faster than the operating base can be resized, since a pure margin problem would typically leave efficiency improving on a smaller revenue denominator. The volatility is instructive: 2026Q1 printed a 36.0% efficiency ratio with a 7.5% fee share, versus 41.7% and 4.6% in 2026Q3, implying the recent deterioration is concentrated in the shrinking fee line rather than a step-change in expenses.

An equity/assets ratio of 0.14 is conservative by regional bank standards and, combined with dividend payments rising toward $2.6M per quarter against earnings that have remained above $10M, implies capital is being retained considerably faster than it is returned — which is the mechanism behind the ROE dilution seen elsewhere. Because regulatory capital ratios are unavailable in this dataset, we cannot judge buffer headroom or buyback capacity directly, and investors should request CET1 and Tier 1 disclosure before assuming the elevated equity ratio translates into meaningful capital-return flexibility.

At an identical 2.24x book to First Financial, Bank7 is being valued as a premium franchise, yet FFIN pairs that multiple with 15.1% ROE and a 2.5% yield versus Bank7's 1.7%, so the market appears to be paying for balance sheet quality rather than demonstrated earnings power. Compared with BOKF at 1.33x and IBCP at 1.54x book, the premium implies an expectation of convergence toward peer-level returns that the trailing ten quarters — marked by falling ROE and a shrinking fee base — do not yet substantiate, though Simmons First's negative ROE suggests the peer group dispersion is itself unusually wide.